Treatment sequences in EGFR mutant advanced NSCLC

Comparative effectiveness of first-/second-generation EGFR-TKI combination therapy versus third-generation EGFR-TKI monotherapy in untreated locally advanced or metastatic EGFR-mutant NSCLC: a real-world, retrospective study in China
Xinwei Wu, Danni Wang, Yangbin Shi +8
BMC Medicine19 Oct 2026Peer-reviewedCC BY-NC-ND 4.0General medicineCrossref
Dacomitinib With or Without Dose Titration in Treatment-Naive Advanced EGFR-Mutated NSCLC — Primary Analysis of the ATORG-003 Phase 2 Trial
Aaron C. Tan, Tae Min Kim, Siqin Zhou +11
JTO clinical and research reports1 Jun 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
Genomic co-alteration patterns are associated with differential benefit from first-line third-generation EGFR-TKI plus chemotherapy versus TKI monotherapy in advanced EGFR-mutant NSCLC
Lili Bai, Huijie Wu, Yue Jiang +4
Frontiers in Medicine21 Oct 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMC
Should we wait?-timing of SRS in EGFR-mutant NSCLC.
Michael T Milano, Amit K Chowdhry, Nicholas J Denunzio +1
Translational lung cancer research19 Oct 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L)
Yoshihiko Sakata, Kenta Murotani, Daichi Fujimoto +18
JTO clinical and research reports24 Jul 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC

Cite

BibTeX

@article{mylene2026treatment,
  title = {{Treatment sequences in EGFR mutant advanced NSCLC}},
  author = {Wespiser Mylène and A. Swalduz and M. Pérol},
  journal = {Lung Cancer},
  year = {2026},
  month = sep,
  doi = {10.1016/j.lungcan.2024.107895},
  url = {https://hal.science/hal-05750184v1},
}

RIS

TY  - JOUR
TI  - Treatment sequences in EGFR mutant advanced NSCLC
AU  - Wespiser Mylène
AU  - A. Swalduz
AU  - M. Pérol
PY  - 2026
DA  - 2026/09/15
JO  - Lung Cancer
DO  - 10.1016/j.lungcan.2024.107895
UR  - https://hal.science/hal-05750184v1
SN  - 0169-5002
ER  -

Related

Cite